We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+59.82%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.55B
AUM Growth
+$107M
Cap. Flow
-$72.8M
Cap. Flow %
-4.7%
Top 10 Hldgs %
49.99%
Holding
236
New
61
Increased
26
Reduced
57
Closed
43

Top Buys

Rank Stock Value
1
KDMN
Kadmon Holdings, Inc.
KDMN
+$20.1M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$17.8M
3
RDUS
Radius Health, Inc.
RDUS
+$15.9M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$14.4M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$13.6M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$45.8M
2
TSRO
TESARO, Inc.
TSRO
+$43.1M
3
NVRO
NEVRO CORP.
NVRO
+$31.9M
4
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$25.3M
5
STJ
St Jude Medical
STJ
+$18.2M

Sector Composition

Rank Sector Weight
1 Healthcare 96.62%
2 Miscellaneous 2.58%
3 Consumer Staples 0.5%
4 Technology 0.1%
5 Consumer Discretionary 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDX icon
26
Ardelyx
ARDX
$878M
$13.7M 0.88%
1,057,257
+741,302
+235% +$7.77M
BPMC
27
DELISTED
Blueprint Medicines
BPMC
$13.7M 0.88%
460,024
-4,380
-0.9% -$109K
ASRT
28
DELISTED
Assertio
ASRT
$13.4M 0.86%
8,917
-1,083
-11% -$1.36M
ALDR
29
DELISTED
Alder Biopharmaceuticals
ALDR
$12.8M 0.83%
391,280
-8,720
-2% -$266K
FOMX
30
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$12.7M 0.82%
1,373,284
+578,284
+73% +$4.83M
NERV icon
31
Minerva Neurosciences
NERV
$183M
$11.4M 0.74%
101,317
– –
ZYNE
32
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$11.3M 0.73%
868,897
+19,547
+2% +$186K
DERM
33
DELISTED
Dermira, Inc.
DERM
$11.2M 0.72%
331,610
-130,390
-28% -$4.2M
CLSD
34
DELISTED
Clearside Biomedical
CLSD
$11M 0.71%
42,320
-1
-0% -$122
ACRS icon
35
Aclaris Therapeutics
ACRS
$814M
$11M 0.71%
+430,000
New +$9.12M
EVH icon
36
Evolent Health
EVH
$423M
$10.5M 0.68%
428,284
-444,780
-51% -$10.4M
VBIV
37
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$10.5M 0.68%
101,948
– –
MYOK
38
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10.4M 0.67%
634,894
+132,000
+26% +$2.38M
QURE icon
39
uniQure
QURE
$2.99B
$10M 0.65%
1,312,836
-29,257
-2% -$232K
VRTX icon
40
Vertex Pharmaceuticals
VRTX
$130B
$9.33M 0.6%
107,000
-23,000
-18% -$2.17M
CDTX
41
DELISTED
Cidara Therapeutics
CDTX
$8.86M 0.57%
38,668
-975
-2% -$225K
FPRX
42
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$8.74M 0.56%
166,509
-2,930
-2% -$140K
FWP
43
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$8.49M 0.55%
57,782
+13,296
+30% +$1.87M
PFNX
44
DELISTED
Pfenex Inc.
PFNX
$8.41M 0.54%
939,930
-20,947
-2% -$179K
ABMD
45
DELISTED
Abiomed Inc
ABMD
$8.14M 0.53%
63,290
+48,590
+331% +$5.82M
ABEO icon
46
Abeona Therapeutics
ABEO
$313M
$8.02M 0.52%
53,442
-17,073
-24% -$1.67M
AVXS
47
DELISTED
AveXis, Inc. Common Stock
AVXS
$7.83M 0.51%
190,000
+188,485
+12,441% +$7.16M
EYPT icon
48
EyePoint Inc
EYPT
$316M
$7.68M 0.5%
255,243
-11,257
-4% -$408K
ACHN
49
DELISTED
Achillion Pharmaceuticals
ACHN
$7.53M 0.49%
+929,290
New +$7.9M
AKBA icon
50
Akebia Therapeutics
AKBA
$250M
$7.29M 0.47%
809,096
-84,504
-9% -$718K
1
2
3 4 5

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Perceptive Advisors held 236 positions worth $1.55B, up 7.4% from $1.44B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors withdrew a net $72.8M in Q3 2016, closing 43 positions and reducing 57 holdings. Its most notable exit was MEDIVATION, INC., an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 79% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Kadmon Holdings, Inc. worth $16.2M.

  • Perceptive Advisors's largest Q3 2016 buy was Kadmon Holdings, Inc.: 2,209,657 shares worth $16.2M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2016, an estimated $14.4M increase.
  • Perceptive Advisors's biggest Q3 2016 reduction was TESARO, Inc., cutting an estimated $43.1M.
  • Perceptive Advisors fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $45.8M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.55B portfolio in Q3 2016.
  • Perceptive Advisors opened 61 new positions and closed 43 in Q3 2016.
  • Perceptive Advisors's portfolio value rose 7.4% quarter-over-quarter to $1.55B.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.